Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Edoardo Pennesi

Edoardo Pennesi

PhD student
Early phase clinical trials in pediatric oncology
Phone
Email e.pennesi@prinsesmaximacentrum.nl

 




  • A Phase I/II study of Bosutinib in pediatric patients with newly diagnosed chronic phase or resistant/intolerant Ph+ Chronic Myeloid Leukemia
  • A phase I/II study of Inotuzumab Ozogamicin as a single agent and in combination with chemotherapy for pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukemia
  • Gabapentin for the treatment of vincristine induced neuropathy in the pediatric oncology setting

Publications

1 publications in total

  • Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia

    • jun. 2022
    • Edoardo, Pennesi, et al
    • Leukemia
View all publications